Chengcheng Yao

The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC

Yueping Jin, Hui Dong, Liliang Xia et al. · Journal of Thoracic Oncology · 2019 · 566 citations · Full text

Life Sciences, Immunology, Oncology +17

Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer

Liliang Xia, Hui Wang, Mingjiao Sun et al. · Science China Life Sciences · 2021 · 32 citations

Medicine, Immunology, Oncology +16

LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production

Meiyu Zhang, Chengcheng Yao, Jun Cai et al. · Journal of Translational Medicine · 2019 · 30 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

<i>NLRP4</i> negatively regulates type I interferon response and influences the outcome in anti‐programmed cell death protein (PD)‐1/PD‐ligand 1 therapy

Hui Wang, Liliang Xia, Chengcheng Yao et al. · Cancer Science · 2021 · 22 citations · Full text

Medicine, Immunology, Oncology +17

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Jianglan Long, Meng Li, Chengcheng Yao et al. · International Journal of Biological Macromolecules · 2024 · 15 citations

Life Sciences, Biochemistry, Microbiology +13